Hôpital Saint-andré

Bordeaux 33075

0 studies enrolling now · 11 studies all time

What they study most

Advanced Cancer, Advanced Cutaneous Squamous Cell Carcinoma, Cardiovascular Diseases, Critical Limb Ischemia, HIV Infections, HIV-1-infection, Head and Neck Cancer, Hypertension, Lung Cancer, Melanoma, Metastatic Renal Cell Carcinoma, Metastatic or Unresectable Cutaneous Melanoma

Studies at this site

• A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) — Completed
• Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma — Completed
• The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension — Running, not enrolling
• Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors — Status unconfirmed
• Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients — Completed
• Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed
• Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia — Stopped early
• Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed
• IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma — Completed
• Expanded Access Program for Maraviroc At Multiple Centers — Completed